GENTAUR Contact Gentaur




+32 1658 9045
+32 1650 9045


tel +32 2 732 5688
fax +32 2 732 4414
Av. de l' Armée 68
B-1040 Brussels


tel 01 43 25 01 50
fax 01 43 25 01 60
9, rue Lagrange
75005 Paris


tel 02 36 00 65 93
fax 02 36 00 65 94
20135 Milano


tel +32 16 58 90 45
fax +32 16 50 90 45
Forckenbeckstraße 6
D-52074 Aachen


tel +81 78 386 0860
fax +81 78 306 0296
Chuo-ku, Kobe

Stabil-P.A.C. NV10 Stabilises Fusion Proteins after Tag Cleavage

The expression of recombinant proteins with fusion partners can result in enhanced expression yields, increased
solubility and an improved purification route. Subsequent site specific proteolysis is often required to remove these
fusion partners after purification in order to produce native protein. However, cleavage of fusion tags which have
been added to enhance solubility frequently results in protein aggregation and loss of yield. The presence of NV10
in cleavage buffers greatly improves protein solubility while maintaining high cleavage efficiency. NV10 can be
readily removed from cleaved protein solutions by ion exchange or affinity chromatography, but its compatibility with
many downstream applications often allows the user to retain NV10 in solution with target protein, maintaining
protein solubility and stability.


Aggregation and stability are very protein specific, but a general protocol is given below.

       1. Determine the starting protein concentration (using eg.
Bradford assay, BCA assay, absorbance at 280nm).
       2. Typically a fivefold excess, by mass, of NV10 will protect the target fusion protein. For example, use 5 mg/ml
            NV10 for 1 mg/ml protein.
        3. Each Stabil-P.A.C. tube contains 1.25 mg NV10 as a lyophilised powder.
        4. Add the protein solution to NV10 in Stabil-P.A.C. tubes to get the desired concentration, or make up a
            10 mg/ml stock of NV10 (4 X stock) by adding 125 μL of buffer or distilled water to each Stabil-P.A.C. tube
             and add this stock to the protein cleavage solution before adding the protease.
        5. Alternatively, make up the cleavage buffer with the desired NV10 concentration, and use
PD10 desalting
columns to buffer exchange the target fusion protein into cleavage buffer containing NV10.
        6. Continue with tag cleavage according to the standard protocol.
        7. NV10 associates with the protein in solution and protects the cleaved native protein from aggregation and
        8. NV10 1X stock solution can be stored for 1 week at 4 oC or for longer term at -20 oC.

    • If the protein shows signs of aggregation or heavy losses on cleavage then the relative NV10 concentration
        can be increased, ie increase NV10 concentration and / or reduce protein concentration.
    • Alternatively, a lower NV10 to protein ratio can be used with proteins that have no history of aggregation.

EXAMPLE : Use of NV10 in Fusion Protein Stabilisation

A kinase protein was prepared with maltose binding protein as a fusion partner (k-MBP) to enable facile purification
and high solubility. Cleavage of the fusion tag using Factor Xa routinely resulted in heavy aggregation and
associated low yields of the native kinase. 1 mg/ml k-MBP was prepared in cleavage buffer (20 mM Tris.HCl,
75 mM NaCl, 1 mM CaCl2, pH 6.5) containing an increasing concentration of NV10, and then the protease
Factor Xa was added to initiate cleavage of the MBP tag. The solutions were incubated at room temperature for
4 hours, and aggregation was monitored at intervals of 1 hour. The absorbance at 492 nm was used as a
measurement of aggregation.




Cleavage of the fusion tag from k-MBP using a standard cleavage buffer results in severe aggregation and loss of
protein yield as indicated by relatively high absorbance values at 492nm. The presence of NV10 in the cleavage
buffer significantly reduces aggregation, and this is virtually eliminated at a ratio of 5 mg/ml NV10 : 1 mg/ml protein
or above.


NV10 can protect proteins from aggregation and loss of yield after fusion tag cleavage.

Home Up

send mail to with questions or comments about this web site.
Copyright © 2008 Gentaur Molecular Products
Site powered by Acid Dragon (AC)
Last modified: 05/19/16